by Diverticulitis refers to the inflammation or infection of small pouches called diverticula that bulge out from the colon wall. It is a common gastrointestinal condition affecting nearly 50-60% of adults over the age of 60. Diverticula usually do not cause any symptoms but can get infected due to straining during bowel movements from low-fiber diet, leading to diverticulitis. Symptoms include abdominal pain, tenderness, and swelling on the lower left side of the abdomen. Diagnosis involves physical examination, medical history, blood work, CT scan and colonoscopy. Treatment depends on severity and includes antibiotics, dietary changes, medications, or surgery in extreme cases. Innovations in diagnostic imaging modalities as well as minimally invasive surgical techniques have aided in effective management of diverticulitis.
The global diverticulitis diagnostic market is estimated to be valued at US$ 1.2 Billion in 2030 and is expected to exhibit a CAGR of 5.5% over the forecast period 2025-2030.
Key Takeaways
Key players operating in the diverticulitis market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd.
Rising incidents of diverticulosis and diverticulitis owing to sedentary lifestyles and unhealthy eating habits will create growth opportunities for market players.
Advancements such as CT colonography, MRI enterography and colon capsule endoscopy have improved detection capabilities and reduced needs for invasive diagnostic methods like colonoscopy. Newer techniques for minimally invasive surgeries like laparoscopic and robotic-assisted surgeries are also gaining traction.
Market Drivers
Increasing geriatric population prone to diverticulitis due to age-related weakening of colon muscles is a key factor driving the market growth. Moreover, rising health awareness and diagnostic capabilities are enabling improved case detection rates globally. Adoption of novel minimally invasive treatment methods is also providing an impetus to market expansion.
Current Challenges in Diverticulitis Market
The diverticulitis market is facing various challenges. Treatment options are limited and expensive. Diagnosis is difficult in early stages of the disease. Most patients have mild or no symptoms in early stages. By the time severe symptoms appear, it may require invasive surgery. Research on new treatment options is still at nascent stage. Lack of awareness among people adds to challenges. Many people do not realize they have diverticulitis until severe symptoms appear. Rising healthcare costs also impact people’s access to timely treatment.
SWOT Analysis
Strength: Non-surgical treatment options like antibiotics provide early relief without invasive surgery. Growing research on probiotics and lifestyle changes.
Weakness: Limited approved drugs for long term management. Surgery still the only treatment for advanced cases. High recurrence rate post-surgery.
Opportunity: Growing elderly population increases market potential. Scope for development of new drugs and non-invasive treatments. Nutraceuticals and probiotics offer opportunities.
Threats: Entry of generics poses pricing pressure. Alternate treatment options like changes in diet can reduce dependence on medicines.
European region accounts for the major share in terms of value in diverticulitis market. High awareness, universal healthcare and aging population drive the European market.
The Asia Pacific region is poised to be the fastest growing market for diverticulitis due to increasing incidence of disease, growing healthcare spending and expanding medical tourism. Rising lifestyle changes and diet habits also contribute to growth of Asian diverticulitis market.
What Are The Key Data Covered In This Diverticulitis Diagnostic Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Diverticulitis Diagnostic ‘s growth between 2024 and 2031.
:- Accurate calculation of the size of the Diverticulitis Diagnostic and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Diverticulitis Diagnostic Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Diverticulitis Diagnostic vendors
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
